Literature DB >> 9333067

Low-level release of Shiga-like toxin (verocytotoxin) and endotoxin from enterohemorrhagic Escherichia coli treated with imipenem.

K Takahashi1, K Narita, Y Kato, T Sugiyama, N Koide, T Yoshida, T Yokochi.   

Abstract

Shiga-like toxin (SLT) and endotoxin may participate in the pathogenesis of enterohemorrhagic Escherichia coli (EHEC) infection. Levels of release of SLT and endotoxin from EHEC treated in vitro with antibiotics were estimated. There were differential levels of release of SLT and endotoxin from EHEC treated with different antibiotics. Treatment of EHEC strains, namely, E. coli O157, O111, and O26, with imipenem induced much lower levels of release of SLT and endotoxin than treatment with ceftazidime.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9333067      PMCID： PMC164112     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  10 in total

Review 1.  Antibiotic-induced release of endotoxin: a reappraisal.

Authors:  J C Hurley
Journal:  Clin Infect Dis       Date:  1992-11       Impact factor: 9.079

2.  Effects of different types and combinations of antimicrobial agents on endotoxin release from gram-negative bacteria: an in-vitro and in-vivo study.

Authors:  A S Dofferhoff; J H Nijland; H G de Vries-Hospers; P O Mulder; J Weits; V J Bom
Journal:  Scand J Infect Dis       Date:  1991

3.  beta-Lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP) 2-specific imipenem and PBP 3-specific ceftazidime.

Authors:  J J Jackson; H Kropp
Journal:  J Infect Dis       Date:  1992-06       Impact factor: 5.226

Review 4.  Shiga and Shiga-like toxins.

Authors:  A D O'Brien; R K Holmes
Journal:  Microbiol Rev       Date:  1987-06

5.  Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities.

Authors:  N A Strockbine; L R Marques; J W Newland; H W Smith; R K Holmes; A D O'Brien
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

6.  Differential release of smooth-type lipopolysaccharide from Pseudomonas aeruginosa treated with carbapenem antibiotics and its relation to production of tumor necrosis factor alpha and nitric oxide.

Authors:  T Yokochi; A Kusumi; N Kido; Y Kato; T Sugiyama; N Koide; G Z Jiang; K Narita; K Takahashi
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

7.  Effect of antibiotics on endotoxin release from gram-negative bacteria.

Authors:  R H Eng; S M Smith; P Fan-Havard; T Ogbara
Journal:  Diagn Microbiol Infect Dis       Date:  1993 Mar-Apr       Impact factor: 2.803

Review 8.  Clinical relevance of antibiotic-induced endotoxin release.

Authors:  J M Prins; S J van Deventer; E J Kuijper; P Speelman
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

Review 9.  Escherichia coli cytotoxins and enterotoxins.

Authors:  C L Gyles
Journal:  Can J Microbiol       Date:  1992-07       Impact factor: 2.419

Review 10.  Infection by verocytotoxin-producing Escherichia coli.

Authors:  M A Karmali
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132
  10 in total
  4 in total

1.  Nitrite reductase from Pseudomonas aeruginosa released by antimicrobial agents and complement induces interleukin-8 production in bronchial epithelial cells.

Authors:  B Sar; K Oishi; A Wada; T Hirayama; K Matsushima; T Nagatake
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

2.  Morphological change in Pseudomonas aeruginosa following antibiotic treatment of experimental infection in mice and its relation to susceptibility to phagocytosis and to release of endotoxin.

Authors:  T Yokochi; K Narita; A Morikawa; K Takahashi; Y Kato; T Sugiyama; N Koide; M Kawai; M Fukada; T Yoshida
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

3.  Rifaximin does not induce toxin production or phage-mediated lysis of Shiga toxin-producing Escherichia coli.

Authors:  Theresa J Ochoa; Jane Chen; Christopher M Walker; Elsa Gonzales; Thomas G Cleary
Journal:  Antimicrob Agents Chemother       Date:  2007-05-25       Impact factor: 5.191

4.  Toxin gene expression by shiga toxin-producing Escherichia coli: the role of antibiotics and the bacterial SOS response.

Authors:  P T Kimmitt; C R Harwood; M R Barer
Journal:  Emerg Infect Dis       Date:  2000 Sep-Oct       Impact factor: 6.883
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.